Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back
Attendees who have favorited this...
Jummai Apata
DHHS/FDA
Richard Brook
President
Better Health Worldwide, Inc
Anouk Deruaz Luyet
Annie Druet Cabanac
Senior Pharmacoepidemiologist Lead
Servier
Sharon Essink
Utrecht University
Sara Hallum
Epidemiologist
Danish Medicine Agency
Lotte Husemoen
Principal Epidemiologist
Novo Nordisk
Hugo JOURDAIN
EPI-Phare
Kazuhiro Kajiyama
Pharmaceuticals and Medical Devices Agency
Moritz Kapp
Global Safety Leader
Bayer AG
Oystein Karlstad
Senior researcher
Norwegian Institute of Public Health
Andrew Kwist
Policy Lead
Acumen, LLC
Hopin Lee
Senior Consultant
IQVIA
James Lewis
Perelman School of Medicine at the University of Pennsylvania
Hu Li
Gilead Sciences
Zhiwen Liu
Janssen Pharmaceuticals, Inc.
Katja Lophaven
LEO Pharma A/S
Yi Lu
Evidera | PPD
Jennifer Lund
Associate Professor
UNC Gillings School of Global Public Health
Elizabeth Mansi
Dr.
University of Edinburgh
Kristin Meyers
Director
Eli Lilly and Company
Keran Moll
Helena Norberg
Postdoctor
Umea University, Sweden
Marita Olsson
Sr Director Statistical Sciences
AstraZeneca
Jihye Park
UNC Gillings School of Global Public Health
Emily Peach
Associate Director, Epidemiology
AstraZeneca
Lawrence Rasouliyan
Head, Biostatistics & Data Science
OMNY Health
Maria Sanchez-Santos
Statistician/Epidemiologist
CSM, NDORMS, University of Oxford
Yuhuan Shih
Clinicpharm
NCKU Institute of Clinical Pharmacy and Pharmaceutical Sciences
Lina Sy
Kaiser Permanente Southern California, Department of Research & Evaluation
Justine van Tongeren
Dutch Medicines Evaluation Board
Catherine Vasilakis-Scaramozza
Boston Collaborative Drug Surveillance Program
Jannik Wheler
Department of Clinical Epidemiology, Aarhus University & Aarhus University Hospital
